ARFID is not as rare as many people assume. In the general population, estimates range from about 0.3% to 2% in adults and up to 6% or higher in children, putting it roughly on par with better-known eating disorders like anorexia nervosa. The perception that it’s uncommon has more to do with how recently it was recognized and how often it goes undetected than with how many people actually have it.
How Common ARFID Actually Is
Avoidant/restrictive food intake disorder was only added to the official psychiatric diagnostic manual in 2013, replacing a narrower childhood feeding diagnosis. That means researchers are still catching up on solid prevalence data, and the numbers vary widely depending on the population studied and the methods used.
In nonclinical samples of children and adolescents, prevalence estimates range from 0.3% to as high as 15.5%. A large Dutch study of nearly 3,000 children found that 6.4% met criteria for ARFID symptoms. In adults, the general population estimate sits around 0.3% to 2%, though rates climb significantly in clinical settings. Among people being seen at eating disorder clinics, ARFID accounts for 5% to 64% of cases depending on the specialty.
To put those numbers in context: in the same adolescent populations where ARFID has been measured, anorexia nervosa affects about 0.5% and binge eating disorder about 0.8%. ARFID’s prevalence is comparable to both. It is not a niche condition.
Why It Seems Rarer Than It Is
Several factors make ARFID appear uncommon. The biggest is underdetection. Research consistently shows that ARFID often goes undiagnosed, and people with ARFID tend to have a longer duration of illness before receiving any medical attention compared to those with other eating disorders. Part of the problem is that no brief, validated screening tool for ARFID existed for years after its introduction, so standard eating disorder assessments simply missed it. Many screening instruments were designed to catch weight and body image concerns, which are hallmarks of anorexia and bulimia but not ARFID.
There’s also a cultural dismissal factor. In children, ARFID symptoms are frequently written off as “picky eating.” In adults, restrictive eating that doesn’t involve a desire to lose weight can confuse clinicians unfamiliar with the diagnosis. Because ARFID doesn’t involve body image distortion, it falls outside the pattern most people associate with eating disorders, making it invisible in both medical and social settings.
Who Is Most Affected
ARFID is more commonly identified in children and adolescents than in adults, though this may partly reflect the fact that pediatric feeding problems are more likely to come to clinical attention. Unlike anorexia and bulimia, which disproportionately affect women and girls, ARFID appears to have a more even gender distribution, with higher rates among boys and men than other eating disorders typically show.
The overlap with neurodevelopmental conditions is significant. A meta-analysis pooling data from 18 studies found that about 16% of people with ARFID also have an autism diagnosis. Looking at it from the other direction, roughly 11% of autistic individuals meet criteria for ARFID. Sensory sensitivities, which are central to many ARFID presentations, are also a core feature of autism, so the connection makes biological sense. ADHD and anxiety disorders are also commonly seen alongside ARFID, though prevalence data for those overlaps is less precise.
What ARFID Looks Like
ARFID isn’t just being a picky eater. A diagnosis requires that the restricted eating leads to at least one measurable consequence: significant weight loss, nutritional deficiencies, dependence on nutritional supplements or tube feeding, or meaningful interference with social functioning. The restriction can stem from low appetite, strong sensory aversions to food textures, tastes, or smells, or a fear of negative consequences from eating (like choking or vomiting). Crucially, the avoidance is not driven by concerns about weight or body shape, which is what separates ARFID from anorexia.
The physical toll can be serious. A systematic review of health complications in children and young people with ARFID found widespread nutritional deficiencies. One study reported that 67% of individuals with ARFID consumed less than 80% of the daily recommended intake of six or more essential nutrients. Between 23% and 74% of those studied had electrolyte imbalances. Low bone mineral density is common, with one study finding that 25% of people with ARFID had dangerously low bone density in their spine and 77% had at least mildly reduced levels. Growth delays, delayed puberty, and in some cases heart rate abnormalities have also been documented.
Beyond the physical effects, ARFID creates real social consequences. Avoiding restaurants, family meals, travel, and social gatherings where unfamiliar food might be present is a pattern that can shrink someone’s world considerably over time.
Treatment and Outlook
ARFID treatment is still evolving, but outcomes from specialized programs are encouraging. Cognitive behavioral therapy adapted specifically for ARFID (sometimes called CBT-AR) has shown good results both as a standalone approach and as part of more intensive treatment packages. The therapy typically works on gradually expanding the range of tolerated foods while addressing the underlying fears or sensory responses driving the avoidance.
The challenge is access. Because ARFID was only formally recognized a little over a decade ago, many eating disorder programs and general practitioners are still not equipped to identify or treat it. People with ARFID often cycle through gastroenterology appointments, allergy testing, and general nutrition counseling before landing on the correct diagnosis. If the numbers from population studies are accurate, millions of people worldwide have ARFID, and the vast majority have never been told that what they experience has a name and a treatment pathway.